**Question:** All of the following are true regarding enoxaparin EXCEPT:

A. Enoxaparin is a low molecular weight heparin (LMWH)
B. Enoxaparin is a prodrug that requires activation
C. Enoxaparin is used for thromboprophylaxis
D. Enoxaparin is contraindicated in patients with significant renal impairment

**Correct Answer: B. Enoxaparin is a prodrug that requires activation**

**Core Concept:** Enoxaparin is an anticoagulant medication primarily used for thromboprophylaxis in a variety of clinical scenarios. Enoxaparin is a low molecular weight heparin (LMWH) which is a type of anticoagulant drug derived from unfractionated heparin (UFH). LMWHs are designed to have a higher affinity for antithrombin III, a key protein involved in the inhibition of coagulation factors (II, X, Xa, XIa, XIIa, and XIIIa).

**Why the Correct Answer is Right:** Enoxaparin is classified as a prodrug, which means that it requires activation to become biologically active. In the case of enoxaparin, activation occurs in the liver through a series of enzymatic reactions involving UFH and antithrombin III. This activation process is essential for the drug to exert its anticoagulant effects.

**Why Each Wrong Option is Incorrect:**

**A. Enoxaparin is a low molecular weight heparin (LMWH):**
This statement is correct, as enoxaparin is indeed a low molecular weight heparin, which is an essential characteristic for its anticoagulant effect as it binds to antithrombin III more strongly than unfractionated heparin, thereby preventing thrombin and factor Xa activation.

**C. Enoxaparin is used for thromboprophylaxis:**
This statement is also correct, as enoxaparin is commonly used for thromboprophylaxis in various clinical settings, such as deep vein thrombosis, pulmonary embolism, and stroke prophylaxis.

**D. Enoxaparin is contraindicated in patients with significant renal impairment:**
This statement is partially correct, as enoxaparin is contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min) due to the risk of bleeding complications. However, it is not contraindicated in patients with mild to moderate renal impairment (creatinine clearance between 30-50 mL/min). In fact, enoxaparin is often used in these patients as an alternative to unfractionated heparin due to its favorable pharmacokinetic and pharmacodynamic properties. **Why Option B is Incorrect:** Option B states that enoxaparin is a prodrug, which is incorrect. Enoxaparin is a low molecular weight heparin (LMWH) and does require activation through interaction with antithrombin III, but it is not a prodrug. A prodrug is a substance that needs to be converted into its active form by an enzymatic process.